We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP37603
Abstract: CAR-T cell therapy development is a complicated process that combines several key technologies from early stage preparation to clinical manufacturing. Each step requires robust and controllable methodology, operation, and strict quality control. Summary: CAR-T cell therapy development is a complicated process that combines several key technologies from early stage preparation to clinical manufacturing. Each step requires robust and controllable methodology, operation, and strict quality control. References: https://www.creative-biolabs.com/car-t/one-stop-car-t-therapy-development-services.htm
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Generating antimicrobial peptides using generative adversarial networks.
Khondamir Rustamov
RWE Thought Experiment: Could RWE Have Prevented Today's Opioid Epidemic? Lessons from 19th Century China
Sheila Mahoney MBA, LifeSciHub LLC, William John, MD, Duke Medical School, Luo Zhou, Chinese Studies Librarian Duke University Libraries
PBPK/RO modeling of anti-PDL1 antibodies
Antonina Nikitich, Oleg Demin Jr
In silico identification and characterization of epitope-based peptide of Buffalo TLR4
Shipra Chauhan, Prashant Kumar, Prashant Singh, Anuradha Bhardwaj, Sanjay Kumar, Navneet Saxena, Dharmendra Kumar, Sajjan Singh, T.K.. Datta, Varij Nayan
Modélisation systémique des déterminants de la mise à l’échelle et de la pérennisation des innovations en santé : une étude de cas qualitative au Burkina Faso et au Mali
Marietou Niang; Marie-Pierre Gagnon; Sophie Dupéré
